The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 20, 2021

Filed:

Feb. 16, 2018
Applicant:

Cook Medical Technologies Llc, Bloomington, IN (US);

Inventors:

John Neilan, Gort, IE;

David Murray, Limerick, IE;

James Butler, Aherlow, IE;

Assignee:

Cook Medical Technologies LLC, Bloomington, IN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 31/00 (2006.01); A61L 31/16 (2006.01); A61L 31/02 (2006.01); A61L 31/08 (2006.01); A61L 31/14 (2006.01); A61L 27/08 (2006.01); A61L 27/54 (2006.01);
U.S. Cl.
CPC ...
A61L 31/16 (2013.01); A61L 31/022 (2013.01); A61L 31/024 (2013.01); A61L 31/084 (2013.01); A61L 31/14 (2013.01); A61L 27/08 (2013.01); A61L 27/54 (2013.01); A61L 2400/18 (2013.01); A61L 2420/02 (2013.01);
Abstract

There are disclosed implantable medical devices and apparatus for treating implantable medical devices during production, so as to cause the implantable medical devices to have abluminal surfaces and luminal surfaces with different functional characteristics and in particular surface energies. The luminal surfaces of the medical device are preferably coated with carbon, so as to have a low surface energy, which reduces the risk of thrombi forming when implanted into a patient's vessels. The abluminal surfaces are treated so as to have a high surface energy, such that a therapeutic, preferably bioactive, material, such as a drug, can adhere to the abluminal surfaces and preferably without any need for a containment layer such as polymer or other matrix material. Once the therapeutic material has been delivered into the tissue wall, the stent can remain within the patient's vessel without leaving any delivery artefacts, as occurs with some prior art drug eluting medical devices.


Find Patent Forward Citations

Loading…